Literature DB >> 7325645

Susceptibility of Pittsburgh pneumonia agent (Legionella micdadei) and other newly recognized members of the genus Legionella to nineteen antimicrobial agents.

A W Pasculle, J N Dowling, R S Weyant, J M Sniffen, L G Cordes, G M Gorman, J C Feeley.   

Abstract

The susceptibilities of 11 strains representing the five recognized species of Legionella were determined by agar dilution testing on buffered charcoal-yeast extract agar. All of the legionellae tested were susceptible to rifampin, erythromycin, rosaramycin, chloramphenicol, and the aminoglycosides and were resistant to clindamycin and vancomycin. Susceptibilities to penicillins and cephalosporins were variable. Legionella micdadei, Legionella bozemanii, and Legionella gormanii were susceptible to these agents, but minimal inhibitory concentrations for each species were different. Legionella dumoffii resembled Legionella pneumophila in being resistant to penicillin, cephalothin, and cephamandole and susceptible to moxalactam and cefoxitin. All species except L. micdadei produced beta-lactamase.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7325645      PMCID: PMC181800          DOI: 10.1128/AAC.20.6.793

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Laboratory evaluation of a rapid, automatic susceptibility testing system: report of a collaborative study.

Authors:  C Thornsberry; T L Gavan; J C Sherris; A Balows; J M Matsen; L D Sabath; F Schoenknecht; L D Thrupp; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

2.  Primary isolation media for Legionnaires disease bacterium.

Authors:  J C Feeley; G W Gorman; R E Weaver; D C Mackel; H W Smith
Journal:  J Clin Microbiol       Date:  1978-09       Impact factor: 5.948

3.  Opportunistic pneumonia: a clinicopathological study of five cases caused by an unidentified acid-fast bacterium.

Authors:  B H Rogers; G R Donowitz; G K Walker; S A Harding; M A Sande
Journal:  N Engl J Med       Date:  1979-11-01       Impact factor: 91.245

4.  Opportunistic lung infection due to "Pittsburgh Pneumonia Agent".

Authors:  R L Myerowitz; A W Pasculle; J N Dowling; G J Pazin; M Puerzer; R B Yee; C R Rinaldo; T R Hakala
Journal:  N Engl J Med       Date:  1979-11-01       Impact factor: 91.245

5.  Use of a semiselective medium to culture Legionella pneumophila from contaminated lung specimens.

Authors:  P H Edelstein; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-08       Impact factor: 5.948

6.  A Legionella-like bacterium related to WIGA in a fatal case of pneumonia.

Authors:  B M Thomason; P P Harris; M D Hicklin; J A Blackmon; W Moss; F Matthews
Journal:  Ann Intern Med       Date:  1979-11       Impact factor: 25.391

7.  Atypical Legionella-like organisms: fastidious water-associated bacteria pathogenic for man.

Authors:  L G Cordes; H W Wilkinson; G W Gorman; B J Fikes; D W Fraser
Journal:  Lancet       Date:  1979-11-03       Impact factor: 79.321

8.  Legionella gormanii sp. nov.

Authors:  G K Morris; A Steigerwalt; J C Feeley; E S Wong; W T Martin; C M Patton; D J Brenner
Journal:  J Clin Microbiol       Date:  1980-11       Impact factor: 5.948

9.  New bacterial agent of pneumonia isolated from renal-transplant recipients.

Authors:  A W Pasculle; R L Myerowitz; C R Rinaldo
Journal:  Lancet       Date:  1979-07-14       Impact factor: 79.321

10.  Legionnaires' disease: clinical features of 24 cases.

Authors:  B D Kirby; K M Snyder; R D Meyer; S M Finegold
Journal:  Ann Intern Med       Date:  1978-09       Impact factor: 25.391

View more
  19 in total

Review 1.  Virulence factors of the family Legionellaceae.

Authors:  J N Dowling; A K Saha; R H Glew
Journal:  Microbiol Rev       Date:  1992-03

2.  Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones.

Authors:  S L Pendland; S J Martin; C Chen; P C Schreckenberger; L H Danziger
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

3.  Antimicrobial therapy of experimental Legionella micdadei pneumonia in guinea pigs.

Authors:  A W Pasculle; J N Dowling; F N Frola; D A McDevitt; M A Levi
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

4.  Enhanced primary isolation of Legionella pneumophila from clinical specimens by low-pH treatment.

Authors:  W J Buesching; R A Brust; L W Ayers
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

5.  In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria.

Authors:  T Barlam; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

6.  Characterization of the beta-lactamases of six species of Legionella.

Authors:  R Marre; A A Medeiros; A W Pasculle
Journal:  J Bacteriol       Date:  1982-07       Impact factor: 3.490

7.  [Legionella pneumophila pneumonia masked by simultaneous demonstration of further non-specific pneumonia pathogens].

Authors:  U Dickgiesser; H E Müller; G Böhm; D Fritsche
Journal:  Infection       Date:  1985 Sep-Oct       Impact factor: 3.553

8.  Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs.

Authors:  A Saito; K Sawatari; Y Fukuda; M Nagasawa; H Koga; A Tomonaga; H Nakazato; K Fujita; Y Shigeno; Y Suzuyama
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

9.  Evaluation of roxithromycin (RU-965) versus cephradine in pneumococcal pneumonia.

Authors:  B J Zeluff; P Lowe; H J Koornhof; L O Gentry
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-02       Impact factor: 3.267

10.  Bactericidal activity of antibiotics against Legionella micdadei (Pittsburgh pneumonia agent).

Authors:  J N Dowling; R S Weyant; A W Pasculle
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.